It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Phenolic compounds (PCs) could be applied to reduce reactive oxygen species (ROS) levels, and are used to prevent and treat diseases related to oxidative stress. QSAR study was applied to elucidate the relationship between the molecular descriptors and physicochemical properties of polyphenol analogues and their DPPH radical scavenging capability, to guide the design and discovery of highly-potent antioxidant substances more efficiently. PubMed database was used to collect 99 PCs with antioxidant activity, whereas, 105 negative PCs were found in ChEMBL database; their molecular descriptors were generated with Python's Rdkit package. While the molecular descriptors significantly related to the antioxidant activity of PCs were filtered by t-test. The prediction QSAR model was then established by discriminant analysis, and the obtained model was verified by the back-substitution and Leave-One-Out cross-validation methods along with heat map. It was revealed that the anti-DPPH radical activity of PCs was correlated with the drug-likeness and molecular fingerprints, physicochemical, topological, constitutional and electronic property. The established QSAR model could explicitly predict the antioxidant activity of polyphenols, thus were applicable to evaluate the potential of candidates as antioxidants.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Dali University, School of Public Health, Dali, People’s Republic of China (GRID:grid.440682.c) (ISNI:0000 0001 1866 919X)
2 Dali University, Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, Dali, People’s Republic of China (GRID:grid.440682.c) (ISNI:0000 0001 1866 919X)
3 Dali University, Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, Dali, People’s Republic of China (GRID:grid.440682.c) (ISNI:0000 0001 1866 919X); Dali University, Yunnan Provincial 2011 Collaborative Innovation Center for Entomoceutics, Dali, People’s Republic of China (GRID:grid.440682.c) (ISNI:0000 0001 1866 919X)
4 Affiliated Hospital of Kunming University of Science and Technology, The First People’s Hospital of Yunnan Province, Kunming, People’s Republic of China (GRID:grid.218292.2) (ISNI:0000 0000 8571 108X); Dali University, Yunnan Provincial 2011 Collaborative Innovation Center for Entomoceutics, Dali, People’s Republic of China (GRID:grid.440682.c) (ISNI:0000 0001 1866 919X)
5 PharmaBlock Sciences (Nanjing), Inc., Nanjing, People’s Republic of China (GRID:grid.440682.c)
6 Dali University, School of Public Health, Dali, People’s Republic of China (GRID:grid.440682.c) (ISNI:0000 0001 1866 919X); Dali University, Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, Dali, People’s Republic of China (GRID:grid.440682.c) (ISNI:0000 0001 1866 919X)




